Maciej Niewada
Overview
Explore the profile of Maciej Niewada including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
102
Citations
1701
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Karlinski M, Kobayashi A, Niewada M, Fryze W, Tomczak A, Brola W, et al.
Neurol Neurochir Pol
. 2023 Dec;
58(1):75-83.
PMID: 38037889
Introduction: The Registry of Stroke Care Quality (RES-Q) is used in Poland for quality monitoring by numerous hospitals participating in the Angels Initiative. Our aim was to assess the degree...
12.
Kalo Z, Niewada M, Bereczky T, Goettsch W, Vreman R, Xoxi E, et al.
Expert Rev Pharmacoecon Outcomes Res
. 2023 Nov;
24(2):181-187.
PMID: 37970637
Introduction: The uptake of complex technologies and platforms has resulted in several challenges in the pricing and reimbursement of innovative pharmaceuticals. To address these challenges, plenty of concepts have already...
13.
Mela A, Rdzanek E, Jaroszynski J, Furtak-Niczyporuk M, Jablonski M, Niewada M
Front Pharmacol
. 2023 Oct;
14:1153680.
PMID: 37900165
Our objective was to analyze and compare systematically and structurally reimbursement systems in Poland and other countries. The systems were selected based on recommendations issued by the Polish Agency for...
14.
Jakab I, Dimitrova M, Houyez F, Bereczky T, Fovenyes M, Maravic Z, et al.
Front Public Health
. 2023 Jul;
11:1176200.
PMID: 37465169
Introduction: Meaningful patient involvement in health technology assessment (HTA) is essential in ensuring that the interests of the affected patient population, their families, and the general public are accurately reflected...
15.
Niewada M, Macioch T, Konarska M, Mela A, Goszczynski A, Przekopinska B, et al.
Front Pharmacol
. 2023 Mar;
13:1063178.
PMID: 36937206
The combination of immunotherapy and targeted therapy is currently marking a new era in the treatment of renal cancer. The latest clinical guidelines recommend the use of drug combinations for...
16.
Czlonkowska A, Niewada M, Litwin T, Krainski L, Skowronska M, Piechal A, et al.
Eur J Neurol
. 2022 Nov;
31(11):e15646.
PMID: 36427277
Background And Purpose: Wilson's disease (WD) is a rare autosomal recessive disorder causing excessive copper deposition and a spectrum of manifestations, particularly neurological and hepatic symptoms. We analysed the clinical...
17.
Zalikowska-Gardocka M, Niewada M, Niewinski G, Izycka M, Ratynska A, Zurek M, et al.
Clin Nutr ESPEN
. 2022 Oct;
51:319-322.
PMID: 36184223
Background: Parenteral nutrition-associated liver disease (PNALD) is diagnosed after at least 2 weeks of total parenteral nutrition (PN). However, its symptoms may occur early during PN. The aim of this...
18.
Pietrasik A, Gasecka A, Szarpak L, Pruc M, Kopiec T, Darocha S, et al.
Front Cardiovasc Med
. 2022 Jul;
9:861307.
PMID: 35783825
Background: Catheter-directed therapies (CDT) are an alternative to systemic thrombolysis (ST) in pulmonary embolism (PE) patients, but the mortality benefit of CDT is unclear. Objective: We conducted a systematic review...
19.
Banach M, Kazmierczak J, Mitkowski P, Wita K, Broncel M, Gasior M, et al.
Arch Med Sci
. 2022 May;
18(3):569-576.
PMID: 35591826
No abstract available.
20.
Brola W, Steinborn B, Niewada M, Mazurkiewicz-Beldzinska M, Jozwiak S, Sobolewski P, et al.
Mult Scler Relat Disord
. 2022 Feb;
57:103344.
PMID: 35158453
Background: Epidemiologic data on pediatric-onset multiple sclerosis (POMS) in Central and Eastern Europe are limited. The aim of this study was to determine the incidence, prevalence and the clinical features...